Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-01-16

FDA Approved: NALOXONE HYDROCHLORIDE — Supplemental Application (Mylan Institutional LLC)

View source ↗

Summary

The FDA approved a supplemental application for a generic naloxone hydrochloride product by Mylan Institutional LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone Hydrochloride (Naloxone hydrochloride)

Snippet

SUPPL AP for NALOXONE HYDROCHLORIDE (NALOXONE HYDROCHLORIDE)